48 related articles for article (PubMed ID: 7725748)
1. Stage-Specific Embryonic Antigen-1 (SSEA-1) Expression in Thyroid Tissues.
Xu J; Hardin H; Zhang R; Sundling K; Buehler D; Lloyd RV
Endocr Pathol; 2016 Dec; 27(4):271-275. PubMed ID: 27550342
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and Prognostic Significance of the Expression of Mucins, Simple Mucin Antigens and Histo-Blood Group Antigens in Papillary Thyroid Carcinoma.
Alves P; Soares P; Rossi S; Fonseca E; Sobrinho-Simões M
Endocr Pathol; 1999; 10(4):305-313. PubMed ID: 12114767
[TBL] [Abstract][Full Text] [Related]
3. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.
Miettinen M; Kärkkäinen P
Virchows Arch; 1996 Nov; 429(4-5):213-9. PubMed ID: 8972756
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
Allen SM; Bodenner D; Suen JY; Richter GT
Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
[TBL] [Abstract][Full Text] [Related]
5. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
6. CD15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study Group on Multiple Endocrine Neoplasia of Austria.
Längle F; Soliman T; Neuhold N; Widhalm G; Niederle B; Roka S; Kaserer K; Blauensteiner W; Dam K; Clodi M
World J Surg; 1994; 18(4):583-7. PubMed ID: 7725748
[TBL] [Abstract][Full Text] [Related]
7. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
8. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Fink M; Weinhüsel A; Niederle B; Haas OA
Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
[TBL] [Abstract][Full Text] [Related]
10. Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma.
Neuhold N; Längle F; Gnant M; Hollenstein U; Niederle B
J Cancer Res Clin Oncol; 1992; 118(8):629-34. PubMed ID: 1355485
[TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register.
Raue F; Kotzerke J; Reinwein D; Schröder S; Röher HD; Deckart H; Höfer R; Ritter M; Seif F; Buhr H
Clin Investig; 1993 Jan; 71(1):7-12. PubMed ID: 8095831
[TBL] [Abstract][Full Text] [Related]
13. Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease.
Hsu SM; Jaffe ES
Am J Clin Pathol; 1984 Jul; 82(1):29-32. PubMed ID: 6741873
[TBL] [Abstract][Full Text] [Related]
14. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma.
Tisell LE; Hansson G; Jansson S; Salander H
Surgery; 1986 Jan; 99(1):60-6. PubMed ID: 3942001
[TBL] [Abstract][Full Text] [Related]
15. Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.
Schröder S; Schwarz W; Rehpenning W; Dralle H; Bay V; Böcker W
J Cancer Res Clin Oncol; 1988; 114(3):291-6. PubMed ID: 3260237
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]